Sleep deprivation and cardiovascular diseases

Daghlas and colleagues investigated sleep duration and heart attack in a large UK Biobank cohort, as well as genetically supported analyses. [1] Short and long reported sleep duration can be associated with an increased risk. In the case of long duration, it must be particularly noted that illnesses, restricted activity, or non-restorative sleep can contribute to longer times in bed. A U-shaped curve therefore does not prove that both ends damage via the same mechanism. Self-reporting, time of measurement, and cohort selection limit the transferability.

Randomized sleep restriction can investigate short-term physiological changes, but is limited for years-long disease events. Mendelian randomization uses genetic variants as instruments. It requires, among other things, the assumption that the variants do not influence the endpoint through other pathways. Pleiotropy and population structure can violate this assumption. If different designs point in the same direction, this strengthens the classification, but does not replace a direct study of every conceivable intervention.

Autonomic activation, blood pressure regulation, inflammation, and metabolism are plausible mediating pathways. Sleep-related breathing disorders must be considered as a separate factor. Workload, smoking, and social conditions can also collectively influence sleep and cardiovascular risk. A more comfortable surface can reduce a disturbing factor, but it must first be demonstrably proven to alter sleep. It does not automatically follow that this leads to a measurable reduction in clinical events. For STOLL, the statement of supporting a suitable sleep environment is appropriate; heart protection requires much stronger product-specific evidence.

A relative risk describes a ratio and, without a baseline risk, says little about the absolute number of additional events. In a hypothetical example, a relative increase of twenty percent would lead to 1.2 percent at a baseline risk of one percent, whereas it would lead to twelve percent at ten percent. These figures are purely mathematical examples and not an estimation of a sleep effect. For consultation and research, baseline risk, time period, and uncertainty are therefore stated. Furthermore, a statistically detectable association in a large cohort is not automatically a large, individually modifiable effect.

Sleep is not a uniform eight-hour state. A measurement depends on which sleep stage it occurs in, how long a person was awake beforehand, and at what point of their internal night they are. The same clock time does not necessarily mean the same biological phase for different chronotypes. For a physiological study, sleep schedule, preceding sleep duration, light, meals, and relevant medications are therefore recorded. A single morning value cannot replace a progression. Conversely, frequent blood draws can disturb sleep itself. Continuous signals require a quality check, defined temporal assignment, and an evaluation of missing sections. Group means smooth out individual peaks and transitions. A schematic curve on the accompanying page therefore shows a temporal relationship; it is not a reference curve from which a person can gauge their health. The appropriate measurement method is determined by the question, not by the number of available sensors.

A plausible chain of effects can be: An environment changes comfort or disturbances, which leads to changed sleep, and changed sleep influences a physiological function. Each connection requires its own evidence. An experiment on sleep deprivation does not automatically prove that a high-quality material improves the same function. Likewise, a molecular mechanism does not yet explain how large a practically achievable benefit in everyday life would be. The examination therefore begins with a clearly defined endpoint and a suitable comparison condition. For a product intervention, temperature, lying comfort, expectations, and sounds should be captured as separately as possible. Otherwise, it remains unclear which component explains the change. A biomarker can be revealing without being a validated substitute for recovery, quality of life, or disease risk. For STOLL, the scientifically sound statement is often narrower than the original hypothesis: A low-disturbance environment can support good sleep; a certain hormone level or disease prevention cannot be guaranteed from this.